L3VLUP
ProSign in

ICUI · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

ICUIJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • ICUI
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterICUIJNJ
Q3 202012 holders, $1.1bn30 holders, $26.2bn
Q4 202010 holders, $1.2bn32 holders, $26.6bn
Q1 20219 holders, $1.2bn31 holders, $25.3bn
Q2 20219 holders, $1.1bn37 holders, $25.6bn
Q3 202111 holders, $1.3bn40 holders, $24.1bn
Q4 202111 holders, $1.7bn33 holders, $25.2bn
Q1 20227 holders, $1.6bn35 holders, $28.2bn
Q2 20229 holders, $1.2bn33 holders, $26.9bn
Q3 20227 holders, $802m36 holders, $25.4bn
Q4 20227 holders, $872m35 holders, $27.6bn
Q1 20236 holders, $883m42 holders, $24.5bn
Q2 20236 holders, $919m38 holders, $25.0bn
Q3 20235 holders, $550m37 holders, $18.9bn
Q4 20239 holders, $516m31 holders, $19.0bn
Q1 202410 holders, $569m32 holders, $19.7bn
Q2 202410 holders, $627m35 holders, $20.4bn
Q3 202411 holders, $895m28 holders, $22.3bn
Q4 202411 holders, $670m37 holders, $20.4bn
Q1 202510 holders, $490m32 holders, $20.5bn
Q2 20256 holders, $495m31 holders, $18.4bn
Q3 20255 holders, $527m32 holders, $23.7bn
Q4 20256 holders, $533m29 holders, $27.8bn
Q1 20264 holders, $428m34 holders, $35.6bn
Q2 20264 holders, $502m33 holders, $39.1bn
ICUI

Icu Med Inc

Holders
9
Reported value
$516m
Buyers
7
Sellers
3

Breadth +4 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 33 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only ICUI (2)

Holocene Advisors LP, Point72 Asset Management LP

Only JNJ (24)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Man Group PLC, Markel Group Inc, MFS Investment Management, Quantbot Technologies LP, Renaissance Technologies LLC, Squarepoint Ops LLC, Susquehanna International Group LLP, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Two Sigma Investments LP, Verition Fund Management LLC, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →